Cell line · CVCL_1438
Papers48
1 to 20 of 48
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Dose-dependent induction of epithelial-mesenchymal transition in 3D melanoma models by non-thermal plasma treatment. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Liposome-Polymer Nanoparticles Loaded with Copper Diethyldithiocarbamate and 6-Bromo-Indirubin-3'-Oxime Enable the Treatment of Refractive Melanoma. | Small | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Interferon regulatory factor 4 modulates epigenetic silencing and cancer-critical pathways in melanoma cells. | Mol Oncol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| HTS384 NCI60: The Next Phase of the NCI60 Screen. | Cancer Res | 2024 | Cellosaurus cites it, and its Methods give the RRID and name the line | PubMed | |
| Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950. | Cancer Res Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma. | Elife | 2020 | Its Methods give the RRID and name the line | PubMed | |
| Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines. | iScience | 2019 | Cellosaurus cites it | PubMed | |
| Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types. | Nat Commun | 2019 | Cellosaurus cites it | PubMed | |
| Next-generation characterization of the Cancer Cell Line Encyclopedia. | Nature | 2019 | Cellosaurus cites it | PubMed | |
| An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines. | Cancer Res | 2019 | Cellosaurus cites it | PubMed | |
| CAR T cells targeting αvβ3 integrin are effective against advanced cancer in preclinical models. | Adv Cell Gene Ther | 2018 | Its Methods give the RRID and name the line | PubMed | |
| Genetic alterations in main candidate genes during melanoma progression. | Oncotarget | 2018 | Cellosaurus cites it | PubMed | |
| Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays. | Cancer Cell | 2017 | Cellosaurus cites it | PubMed | |
| A map of mobile DNA insertions in the NCI-60 human cancer cell panel. | Mob DNA | 2016 | Cellosaurus cites it | PubMed | |
| Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR. | Sci Data | 2016 | Cellosaurus cites it | PubMed | |
| A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. | Oncoimmunology | 2014 | Cellosaurus cites it | PubMed | |
| The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF. | Cancer Res | 2014 | Cellosaurus cites it | PubMed | |
| High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner. | PLoS One | 2014 | Cellosaurus cites it | PubMed | |
| Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence. | Cancer Res | 2014 | Cellosaurus cites it | PubMed | |
| The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. | Cancer Metab | 2013 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1438/papers